美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Synthorx, Inc.

67.99

0.0000

成交量：- -

成交额：- -

市值：21.75亿

市盈率：-27.91

高：67.99

开：67.99

低：67.99

收：67.99

52周最高：71.90

52周最低：11.05

股本：3,198.82万

流通股本：613.38万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.4361

每股收益(LYR):-18.1135

净资产收益率：-85.54%

总资产收益率：-31.68%

市净率：14.31

市盈率(LYR):-3.75

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Synthorx, Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

https://synthorx.com/

邮编：

- -

电话：

- -

传真：

- -

简介：

Synthorx, Inc.(NASDAQ:THOR)于2014年1月以Alinos, Inc.之名创立，同年3月，更名为Synthorx, Inc.，总部位于美国加州La Jolla，全职雇员25人 (10/31/2018) ，是一家生物制药公司，专注于延长和改善癌症和自身免疫性疾病患者的生活的药物开发。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/THOR/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"THOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THOR\",,,,,undefined,":{"symbol":"THOR","market":"US","secType":"STK","nameCN":"Synthorx, Inc.","latestPrice":67.99,"timestamp":1579726800000,"preClose":67.99,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":6133818,"shares":31988206,"eps":-2.436144,"marketStatus":"停牌","change":0,"latestTime":"01-22 16:00:00 EST","open":67.99,"high":67.99,"low":67.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.436144,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":67.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THOR\",,,,,undefined,":{"symbol":"THOR","floatShares":6133818,"roa":"-31.68%","roe":"-85.54%","lyrEps":-18.113477,"shares":31988206,"dividePrice":0,"high":67.99,"amplitude":0,"preClose":67.99,"low":67.99,"week52Low":11.05,"pbRate":"14.31","week52High":71.9,"institutionHeld":0.8897,"latestPrice":67.99,"eps":-2.436144,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.436144,"open":67.99,"prevYearClose":69.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-05","symbol":"THOR","fiscalQuarterEnding":"2019/09","expectedEps":-0.5,"name":null,"time":"盘后","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2019-08-01","symbol":"THOR","fiscalQuarterEnding":"2019/06","expectedEps":-0.36,"name":null,"time":"","type":"earning","dateTimestamp":1564632000000,"reportTimeType":"","actualEps":-0.39},{"market":"US","date":"2019-04-30","symbol":"THOR","fiscalQuarterEnding":"2019/03","expectedEps":-0.32,"name":null,"time":"","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"","actualEps":-0.35},{"market":"US","date":"2019-03-12","symbol":"THOR","fiscalQuarterEnding":"2018/12","expectedEps":-0.12,"name":null,"time":"","type":"earning","dateTimestamp":1552363200000,"reportTimeType":"","actualEps":-0.89},{"market":"US","date":"2015-08-04","symbol":"THOR","fiscalQuarterEnding":null,"expectedEps":0.14,"name":null,"time":"盘后","type":"earning","dateTimestamp":1438660800000,"reportTimeType":"post","actualEps":0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THOR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"https://synthorx.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Synthorx, Inc.(NASDAQ:THOR)于2014年1月以Alinos, Inc.之名创立，同年3月，更名为Synthorx, Inc.，总部位于美国加州La Jolla，全职雇员25人 (10/31/2018) ，是一家生物制药公司，专注于延长和改善癌症和自身免疫性疾病患者的生活的药物开发。","exchange":"NASDAQ","name":"Synthorx, Inc.","nameEN":"Synthorx, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"THOR\",market:\"US\",,,undefined,":null}}